| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.3 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |